When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EPZM - Epizyme's NDA Filing Acceptance Moves It Forward Toward New Territory
Epizyme Inc.
Epizyme (EPZM) announced that the FDA had accepted its NDA for tazemetostat for patients with metastatic or locally advanced epithelioid sarcoma not eligible for surgery. This sets up the biotech to potentially obtain approval at the beginning of 2020. Best part of all is that this drug was able to be put up for review after only having completed a Phase 2 study. Epizyme is in good shape, especially because it is on track to submit another NDA to the FDA for accelerated approval. This will be accelerated approval of tazemetostat for follicular